Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RNXT
RENOVORX, INC.
NASDAQ
$2.39
▲ UP 0.84% (0.02)

KEY STATISTICS

Market Cap$107.68 M
52w High$2.59
52w Low$0.70
Dividend Yield—
Frequency—
P/E-8.24
Volume2.08M
Shares Out.45.05M

COMPANY

LEADERSHIP

Shaun R. Bagai
CHIEF EXECUTIVE
Shaun R. Bagai

COMPENSATION 2026

Salary$583,441
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$3,004
Total$1,232,317

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 26, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
17

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$1.06M
NOV
12
THU

PRICE

$2.39 ▲ UP 0.84% (+$0.02)
$2.32$2.40$2.489:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM2.39

About RenovoRx, Inc.

https://renovorx.com ↗

RenovoRx, Inc. is a clinical-stage biopharmaceutical company developing intra-arterial therapies for solid tumors, with its lead product, RenovoGem, in Phase III trials for pancreatic cancer.

INDUSTRY

Biotechnology

A PRODUCT RENOVORX, INC. IS KNOWN FOR

RenovoCath® Delivery System
RenovoCath® Delivery System

RenovoCath® is an FDA-cleared dual-balloon infusion catheter for targeted tumor therapy, part of RenovoRx's TAMP™ platform, now commercially available with initial purchase orders.

COMPETITORS

COMPETITOR
ANGO COMPARE
BSX COMPARE
MMSI COMPARE
TFX COMPARE
TLSI COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Other Operating Segment$266K $238K ▼$563K ▲$909K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.0M

INSTITUTIONAL OWNERSHIP

SHARES OWNED
22.83%
HOLDERS
44
TOP 12 OF 44 · RANKED BY POSITION SIZE
Aigh Capital Management LLC
3.7M sh · $3.68M
Bleichroeder LP
1.7M sh · $1.68M
Vanguard Group Inc
1.6M sh · $1.35M
Bank Of The West
975.0K sh · $2.29M
Awm Investment Company, Inc.
863.8K sh · $1.1M
Geode Capital Management, LLC
381.7K sh · $385.56K
Renaissance Technologies LLC
313.6K sh · $398.21K
Wealthspire Advisors, LLC
252.5K sh · $255.05K
Citadel Advisors LLC
232.7K sh · $235.01K
Northwestern Mutual Wealth Management Co
99.5K sh · $100.45K
Nixon Peabody Trust Co
97.2K sh · $98.14K
Corsair Capital Management, L.P.
93.5K sh · $118.71K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
RYAN UNA S
Purchase · 16.2K shares
2022-04-22
★
DIRECTOR
RYAN UNA S
Purchase · 26.8K shares
2022-04-22
★
DIRECTOR
RYAN UNA S
Purchase · 6.3K shares
2022-03-03
★
DIRECTOR
RYAN UNA S
Purchase · 47.8K shares
2022-03-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
Ascendiant Capital BUY HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
PYPD$5.39COMPARE
ANVS$1.39COMPARE
CELU$1.68COMPARE
ELUT$0.82COMPARE
LTRN$1.91COMPARE
TVRD$1.91COMPARE
CALC$2.17COMPARE
RVPH$0.53COMPARE